| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |